Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1701738

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1701738

Pharmaceutical Excipients Market Size, Share, and Growth Analysis, By Product Type (Organic Chemicals, Inorganic Chemicals), By Functionality (Binders, Fillers/Diluents), By Formulation, By Source, By End User, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 242 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Pharmaceutical Excipients Market size was valued at USD 9.1 billion in 2023 and is poised to grow from USD 9.63 billion in 2024 to USD 15.12 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The pharmaceutical excipients market is poised for significant growth driven by rising demand for innovative drugs and advancements in drug delivery technologies. Increased investments in novel drug development and a surging demand for generic medications present ample opportunities for excipient manufacturers. Additionally, the global expansion of pharmaceutical manufacturing activities is expected to further enhance market prospects. The growing sales of biologics will likely boost demand for specialized excipients. However, challenges such as high manufacturing costs, stringent regulations, raw material supply fluctuations, and competition from alternatives may hinder market progress. North America and the Asia Pacific regions are projected to remain the dominant markets for pharmaceutical excipients, indicating robust commercial potential in these areas in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global Pharmaceutical Excipients Market is segmented by Product Type, Functionality, Formulation, Source, End User and region. Based on Product Type, the market is segmented into Organic Chemicals, Inorganic Chemicals and Others. Based on Functionality, the market is segmented into Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants, Preservatives, Flavors and Sweeteners, Coloring Agents, Solvents and Others. Based on Formulation, the market is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations, Inhalation Formulations, Ophthalmic Formulations, Nasal Formulations and Suppositories. Based on Source, the market is segmented into Natural and Synthetic. Based on End User, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Excipients Market

The escalating costs of drugs and pharmaceuticals globally have sparked a significant surge in the demand for generic medicines. This trend is fueled by a rising focus on enhancing healthcare accessibility and lowering overall healthcare expenses. As a result, the market for generic medicines is expected to see substantial growth, which, in turn, will positively influence the development of the pharmaceutical excipients market. The increasing popularity of generic alternatives is driving innovation and competition, further propelling advancements within the excipients sector, making it an essential component of the pharmaceutical manufacturing process as the industry adapts to these market dynamics.

Restraints in the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market faces significant restraints primarily due to the high research and development costs associated with excipient formulation. The intricate development process necessitates extensive investment throughout the entire product lifecycle, which can elevate overall expenses. Additionally, the growing reliance on advanced manufacturing equipment further contributes to these elevated production costs. As a result, this combination of high development and manufacturing expenses is likely to hinder sales growth in the pharmaceutical excipients sector in the foreseeable future, posing challenges for market expansion and profitability.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a significant trend towards the incorporation of natural and biodegradable ingredients. As consumers increasingly gravitate towards wellness and sustainability, there is a rising demand for drug formulations that utilize natural excipients, steering away from traditional chemical-based alternatives. This shift is driven by a growing demographic that prioritizes health-conscious choices and seeks transparency in product formulations. Consequently, pharmaceutical excipient manufacturers are presented with lucrative opportunities to innovate and expand their product lines by integrating eco-friendly components, thereby aligning with consumer preferences and contributing to the overall growth of this dynamic market.

Product Code: SQMIG35I2120

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Organic Chemicals
    • Carbohydrates
    • Sugars
    • Starches
    • Cellulose and Derivatives
    • Petrochemicals
    • Glycols
    • Povidone
    • Mineral Hydrocarbons
    • Proteins
    • Gelatin
    • Albumin
  • Inorganic Chemicals
    • Calcium Phosphates
    • Calcium Carbonate
    • Magnesium Stearate
    • Sodium Chloride
    • Silicon Dioxide
  • Others
    • Oleochemicals
    • Natural Excipients

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2025-2032)

  • Market Overview
  • Binders
  • Fillers/Diluents
  • Disintegrants
  • Coating Agents
  • Lubricants
  • Preservatives
  • Flavors and Sweeteners
  • Coloring Agents
  • Solvents
  • Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2025-2032)

  • Market Overview
  • Oral Formulations
    • Tablets
    • Capsules
    • Powders
    • Syrups
  • Topical Formulations
    • Creams
    • Ointments
    • Gels
  • Parenteral Formulations
    • Injections
    • IV Infusions
  • Inhalation Formulations
    • Dry Powder Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
  • Ophthalmic Formulations
  • Nasal Formulations
  • Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2025-2032)

  • Market Overview
  • Natural
    • Plant-based
    • Animal-based
  • Synthetic
    • Fully synthetic
    • Semi-synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2025-2032)

  • North America (Product Type, Functionality, Formulation, Source, End User)
    • US
    • Canada
  • Europe (Product Type, Functionality, Formulation, Source, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Functionality, Formulation, Source, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Evonik Industries AG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ashland Global Holdings Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • International Flavors & Fragrances Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roquette Freres - France
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fuji Chemical Industries Co., Ltd. - Japan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wacker Chemie AG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEGGLE GmbH & Co. KG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
  • Key Developments
  • Biogrund GmbH - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nitika Pharmaceutical Specialties Pvt. Ltd. - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • J.M. Huber Corporation - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerry Group plc - Ireland
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colorcon Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DFE Pharma - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Finar Limited - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corel Pharma Chem - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gattefosse - France
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DowDuPont Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!